Proof of Concept Studies: Building Confidence in Respiratory Drug Development

Proof of Concept Studies: Building Confidence in Respiratory Drug Development

by Virtus | Aug 5, 2026 | Respiratory Preclinical Research

Proof of concept studies are a critical milestone in respiratory drug development. Before a therapeutic candidate progresses into large-scale preclinical programmes or clinical trials, researchers need evidence that it produces the intended biological effect. Proof of...
Preclinical Efficacy Testing: Supporting Respiratory Drug Development Through Robust Research

Preclinical Efficacy Testing: Supporting Respiratory Drug Development Through Robust Research

by Virtus | Aug 5, 2026 | Respiratory Preclinical Research

Preclinical efficacy testing is one of the most important stages of respiratory drug development. Before a new therapeutic candidate progresses into clinical trials, researchers must demonstrate that it produces meaningful biological effects within carefully designed...
Respiratory Biomarkers: Their Role in Drug Development and Preclinical Research

Respiratory Biomarkers: Their Role in Drug Development and Preclinical Research

by Virtus | Jun 28, 2026 | Respiratory Preclinical Research

Respiratory biomarkers have become one of the most valuable tools in modern respiratory drug development. They provide measurable biological indicators that help researchers understand disease progression, evaluate therapeutic responses and improve decision-making...
Translational Respiratory Research: Bridging Preclinical Studies and Clinical Success

Translational Respiratory Research: Bridging Preclinical Studies and Clinical Success

by Virtus | Jun 28, 2026 | Respiratory Preclinical Research

Translational respiratory research is one of the most important stages in modern respiratory drug development. While preclinical respiratory research provides valuable insight into disease biology and therapeutic efficacy, translational research ensures that these...
Proof of Concept Studies: Building Confidence in Respiratory Drug Development

Respiratory Drug Discovery: The First Step Towards Developing New Respiratory Therapies

by Virtus | Jun 28, 2026 | Early-Stage Respiratory Drug Development

Respiratory drug discovery is the foundation of every new treatment developed for asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, viral respiratory infections and other lung diseases. Before a medicine reaches clinical trials, researchers...
« Older Entries
Next Entries »

Recent Posts

  • Preclinical COPD Models: Choosing the Right Approach for Drug Development
  • Bronchoalveolar Lavage in Preclinical Respiratory Research
  • In Vitro Respiratory Disease Models: Applications in Preclinical Drug Discovery
  • Preclinical Respiratory Efficacy Studies: Choosing the Right Models, Endpoints and Research Approach
  • Airway Hyperresponsiveness Models in Preclinical Asthma Research

Recent Comments

No comments to show.

Privacy Notice and Cookie Policy





All content © 2022 Virtus Respiratory Research. All Rights Reserved.

Contact